Latanoprost ophthalmic
Generic name: Latanoprost Ophthalmic
Drug class:
Ophthalmic glaucoma agents
Usage of Latanoprost ophthalmic
Latanoprost ophthalmic (for the eyes) is used to treat certain types of glaucoma and other causes of high pressure inside the eye.
Latanoprost ophthalmic may also be used for purposes not listed in this medication guide.
Latanoprost ophthalmic side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Latanoprost may cause serious side effects. Stop using latanoprost and call your doctor at once if you have:
Common side effects of latanoprost ophthalmic may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Latanoprost ophthalmic
You should not use latanoprost ophthalmic if you are allergic to latanoprost or benzalkonium chloride.
Tell your doctor if you have ever had:
Latanoprost ophthalmic is not approved for use by anyone younger than 18 years old.
Latanoprost ophthalmic may cause a gradual change in the color of your eyes or eyelids and lashes, usually an increase in brown pigment. You may also notice increased growth or thickness of your eyelashes. These changes occur slowly and you may not notice them for months or years. Color changes may be permanent even after your treatment ends, and may occur only in the eye being treated. This could result in a cosmetic difference in eye or eyelash color from one eye to the other.
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Alphagan P
- Apraclonidine
- Apraclonidine ophthalmic
- Azopt
- Combigan
- Cosopt
- Cosopt Ocumeter
- Cosopt Ocumeter Plus
- Cosopt PF
- Betagan
- Betaxolol ophthalmic
- Betimol
- Betoptic S
- Bimatoprost
- Bimatoprost ophthalmic
- Bimatoprost ophthalmic implant
- Brimonidine and brinzolamide
- Brimonidine and brinzolamide ophthalmic
- Brimonidine and timolol
- Brimonidine and timolol ophthalmic
- Brimonidine ophthalmic
- Brinzolamide
- Brinzolamide ophthalmic
- Carbachol ophthalmic
- Carteolol
- Carteolol ophthalmic
- Dipivefrin
- Dorzolamide
- Dorzolamide and timolol
- Dorzolamide and timolol ophthalmic
- Dorzolamide ophthalmic
- Durysta
- Echothiophate iodide ophthalmic
- Epinephrine (Ophthalmic)
- Eserine
- Iopidine
- Isopto Carbachol
- Isopto Carpine
- Isopto Eserine
- Istalol
- Izba
- Latanoprost
- Latanoprost and netarsudil ophthalmic
- Latanoprost ophthalmic
- Latanoprostene bunod
- Latanoprostene bunod ophthalmic
- Levobunolol
- Levobunolol ophthalmic
- Lumigan
- Metipranolol
- Miostat
- Netarsudil
- Netarsudil and latanoprost
- Netarsudil ophthalmic
- Ocu-Carpine
- Ocupress
- Ocusert Pilo
- Omidenepag isopropyl
- Omlonti
- Optipranolol
- Phospholine Iodide
- Pilocar
- Pilocarpine ophthalmic
- Pilopine-HS
- Propine
- Rescula
- Rhopressa
- Rocklatan
- Simbrinza
- Tafluprost
- Tafluprost ophthalmic
- Timolol ophthalmic
- Timoptic
- Timoptic Ocudose
- Timoptic Ocumeter
- Timoptic Ocumeter Plus
- Timoptic-XE Ocumeter
- Timoptic-XE Ocumeter Plus
- Travatan Z
- Travoprost
- Travoprost ophthalmic
- Trusopt
- Trusopt Ocumeter
- Trusopt Ocumeter Plus
- Unoprostone
- Vyzulta
- Xalatan
- Xelpros
- Zioptan
How to use Latanoprost ophthalmic
Usual Adult Dose for Intraocular Hypertension:
One eye drop in the affected eye(s) once a day in the eveningComments:-If one dose is missed, treatment should continue with the next dose as normal.-The dose should not exceed one drop in the affected eye(s) daily as more frequent administration may lessen the intraocular pressure lowering effect.-Reduction of the intraocular pressure starts approximately 2 to 4 hours after the first administration with the maximum effect reached after 12 hours.-This drug may be used concomitantly with other topical ophthalmic drugs to lower intraocular pressure.-If more than one topical ophthalmic drug is being used, each one should be administered at least 5 minutes apart.Use:-Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Usual Adult Dose for Glaucoma (Open Angle):
One eye drop in the affected eye(s) once a day in the eveningComments:-If one dose is missed, treatment should continue with the next dose as normal.-The dose should not exceed one drop in the affected eye(s) daily as more frequent administration may lessen the intraocular pressure lowering effect.-Reduction of the intraocular pressure starts approximately 2 to 4 hours after the first administration with the maximum effect reached after 12 hours.-This drug may be used concomitantly with other topical ophthalmic drugs to lower intraocular pressure.-If more than one topical ophthalmic drug is being used, each one should be administered at least 5 minutes apart.Use:-Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Warnings
Follow all directions on your prescription label and read all medication guides or instruction sheets. Tell your doctor if you use other medicines or have other medical conditions or allergies.
What other drugs will affect Latanoprost ophthalmic
Medicine used in the eyes is not likely to be affected by other drugs you use. But many drugs can interact. Tell your doctor about all your current medicines, including prescription and over-the-counter medicines, vitamins, and herbal products.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions